|
WHAT: |
Delaware’s two United States Senators and Member of Congress will tour the new Nemours Biomedical Research labs in the DuPont Experimental Station. The visit will include demonstrations and meetings with researchers performing cutting-edge research into pediatric illness and disease. |
|
WHEN: |
Tuesday, May 1, 1:00 p.m. |
|
WHERE: |
DuPont Experimental Station Building 400 200 Powder Mill Rd, Wilmington, DE 19803 (Enter at the main gate, off Route 141. PLEASE PLAN TO ARRIVE 15 MINUTES EARLY IN ORDER TO REGISTER AT MAIN GATE AND RECEIVE A BADGE)**
|
|
WHO: |
Senator Tom Carper Senator Chris Coons Rep. Lisa Blunt Rochester E. Anders Kolb, MD - Director of the Nemours Center for Cancer and Blood Disorders Dr. Kolb is heavily involved in advanced research programs to find new cancer drugs that are more effective, with fewer side effects. Julie Barthold, MD, Principal Research Scientist, Head of Urology Research Laboratory Dr. Barthold has helped to shape Nemours’ pediatric precision medicine strategy, an area of innovation for Nemours. Dr. Anne Marie Brescia, MD, Division Chief of Rheumatology, expert in pediatric rheumatoid arthritis Roy Proujansky, MD – Chief Executive, Nemours Delaware Valley Operations Other Nemours and Community Leaders
|
|
WHY: |
Nemours Biomedical Research has invited the Delaware Federal Congressional Delegation to learn more about:
|
|
MORE INFO: |
Precision Medicine focuses in on the individual variability in one’s genes, environment, and lifestyle allowing doctors and researchers to more accurately predict which treatment and prevention strategies for a particular disease will work. |
Info about Nemours at the DuPont Experimental Station:
- Nemours Biomedical Research is leasing the 4th and 5th floors of Building 400 consisting of approximately 82,000 sq. ft. of laboratory and supporting office space.
- The Experimental Station has more than 50 buildings and 2.3 million square feet of building space. Building 400, which was constructed in 1983, contains a 250-seat auditorium, multiple conference rooms, and the support facilities required for state-of-the-art medical research.
- Approximately 70 Nemours scientists, clinical investigators, post doctorate fellows and support staff will work at this facility. In addition, approximately 30 students from the University of Delaware and other area universities will participate in research programs using these facilities.
- Nemours Biomedical Research receives extensive federal funding through numerous investigator grant awards and through multi-institutional research grants. Last year Nemours Biomedical Research was ranked 11th in the nation for National Institutes of Health (NIH) pediatric research funding.
- Nemours Biomedical Research consists of the following:
- Nemours Pediatric Urology Research Lab
- Nemours Preclinical Leukemia Testing Lab
- Nemours Cancer Epigenetics Research Lab
- Molecular Regeneration and Neuroimaging Lab
- Nemours Bimolecular Core Lab
- Nemours Skeletal Dysplasia Research Lab
- Nemours Pediatric Lung Research Lab
- Nemours Motor Neuron Diseases Research Lab
- Nemours Tissue and Regenerative Medicine Lab
- Nemours Histotechnology Core Lab
- Nemours Sickle Cell Research Lab
- Nemours Cell Science Core Lab
- Nemours Translational Rheumatology Research Laboratory
CONTACT: Nancy D’Argenio, Public Relations, 302-377-3146, ndargeni@nemours.org
**If you can RSVP with the name of who is coming, we can attempt to get that person’s name on the list at the security gate. This will speed up the process of entrance onto the premises. Otherwise, again, please arrive 15 minutes early in order to register and get a badge permitting entry onto premises.
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.